Litmore Capital
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 21, 2017
Bristol Myers Squibb
|
Post-IPO Equity | $80M | Biotechnology | — |
Nov 1, 2016
Biohaven Pharmaceutical
|
Series Unknown | $80M | Biotechnology | — |
Litmore Capital has had 2 exits. Litmore Capital most notable exits include Biohaven Pharmaceutical , Bristol Myers Squibb
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
May 5, 2017 | Biohaven Pharmaceutical | M&A | Biotechnology | Detail |
Jan 1, 1972 | Bristol Myers Squibb | IPO | Biotechnology | Detail |